It's great that you've started your treatment with Dupixent! Here are some key points from my knowledge base about Dupixent (dupilumab) for prurigo nodularis:

- Effectiveness: Dupilumab has shown promising results in clinical trials. After 24 weeks, 60% of participants experienced improved skin itching scores
- Remission Show Full Answer

It's great that you've started your treatment with Dupixent! Here are some key points from my knowledge base about Dupixent (dupilumab) for prurigo nodularis:

- Effectiveness: Dupilumab has shown promising results in clinical trials. After 24 weeks, 60% of participants experienced improved skin itching scores.
- Remission Rates: 45.3% of participants achieved complete remission, and 43.8% had partial remission after 16 weeks.
- Side Effects: Common side effects include injection site reactions, common cold, muscle pain, diarrhea, and throat pain.

Stay hopeful and give the treatment time to work. Always discuss any concerns with your doctor.

 This AI-generated response comes from MyPrurigoTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Is Prurigo Nodularis an Autoimmune Disease? | MyPrurigoTeam

Does Prurigo Nodularis Ever Go Away, or Is It Lifelong? | MyPrurigoTeam